Louisiana Senate Bill SB493

Louisiana 2020 Regular Session

• Introduced: 3/31/20
• Refer: 5/4/20

Caption

Provides relative to industrial hemp-derived cannabidiol products. (CA7s2.1(A)) (8/1/20)

Impact

The legislation refines the existing legal framework governing the sale of CBD products in Louisiana, removing ambiguities regarding permissible products while reinforcing the need for regulatory compliance. The bill grants the commissioner of the office of alcohol and tobacco control the authority to suspend or revoke permits for violations, which emphasizes the importance of adherence to the new regulatory standards among retailers. This change could have a significant impact on local businesses selling hemp-derived products, shaping the market landscape for CBD in the state.

Summary

Senate Bill 493, introduced by Senator Carter, focuses on the regulation of industrial hemp-derived cannabidiol (CBD) products in Louisiana. The bill aims to clarify existing prohibitions regarding the processing and sale of hemp for inhalation, permitting the sale of hemp rolling papers while maintaining restrictions on other forms of inhalation. Furthermore, the bill stipulates that any alcoholic beverage or food product containing CBD can only be sold if approved as a food additive by the United States Food and Drug Administration.

Sentiment

The general sentiment surrounding SB 493 appears to be favorable among lawmakers who support the reinforcement of regulations that ensure consumer safety and product legitimacy. Supporters argue that clearer guidelines will allow for responsible commercial growth within the industrial hemp market. However, there may be concerns regarding the implications for small business owners and the ease of navigating the regulatory environment related to CBD sales.

Contention

While the bill serves to define and clarify existing regulations, it still presents points of contention regarding enforcement and the potential consequences for non-compliance. The civil penalty provisions could deter some businesses from engaging in the CBD market, leading to debates about the balance between regulation and economic opportunity. Critics may also voice concerns over the government’s role in controlling the hemp-derived product market, specifically regarding individual liberties and business rights.